AR067561A1 - Medicamento para la aplicacion transdermica en animales - Google Patents
Medicamento para la aplicacion transdermica en animalesInfo
- Publication number
- AR067561A1 AR067561A1 ARP080103051A ARP080103051A AR067561A1 AR 067561 A1 AR067561 A1 AR 067561A1 AR P080103051 A ARP080103051 A AR P080103051A AR P080103051 A ARP080103051 A AR P080103051A AR 067561 A1 AR067561 A1 AR 067561A1
- Authority
- AR
- Argentina
- Prior art keywords
- animals
- medicinal product
- pharmaceutical preparations
- transdermal application
- skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Preparaciones farmacéuticas para utilizar en animales, que se aplican sobre el cuero o la piel del animal y cuyo principio activo luego se reabsorbe de forma transdérmica. Reivindicacion 1: preparaciones farmacéuticas que contienen sales de principio activo y coadyuvantes en una mezcla compuesta por a) 40% - 60% (m/m) de un componente lipofilo, b) 40% - 60% (m/m) de un alcohol con la longitud de cadena C1-6 y 0% - 10% de agua. Reivindicacion 5: preparaciones farmacéuticas de acuerdo con la reivindicacion 4, en la que la sustancia analgésica es diclofenaco Na y/o ketoprofeno Na.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007034976A DE102007034976A1 (de) | 2007-07-26 | 2007-07-26 | Arzneimittel zur transdermalen Anwendung bei Tieren |
Publications (1)
Publication Number | Publication Date |
---|---|
AR067561A1 true AR067561A1 (es) | 2009-10-14 |
Family
ID=40157239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080103051A AR067561A1 (es) | 2007-07-26 | 2008-07-16 | Medicamento para la aplicacion transdermica en animales |
Country Status (14)
Country | Link |
---|---|
US (1) | US20100197791A1 (es) |
EP (1) | EP2182921A2 (es) |
JP (1) | JP2010534624A (es) |
AR (1) | AR067561A1 (es) |
AU (1) | AU2008280501A1 (es) |
BR (1) | BRPI0814588A2 (es) |
CA (1) | CA2694386A1 (es) |
CL (1) | CL2008002077A1 (es) |
DE (1) | DE102007034976A1 (es) |
PE (1) | PE20090797A1 (es) |
TW (1) | TW200922622A (es) |
UY (1) | UY31227A1 (es) |
WO (1) | WO2009012908A2 (es) |
ZA (1) | ZA201000514B (es) |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5855411A (ja) | 1981-09-28 | 1983-04-01 | Nitto Electric Ind Co Ltd | 基剤組成物および外用医薬組成物 |
EP0428352B1 (en) | 1989-11-14 | 1995-08-09 | Beta Pharmaceuticals Co. | Anti-inflammatory compositions for external use |
US5093133A (en) | 1990-01-24 | 1992-03-03 | Mcneil-Ppc, Inc. | Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
TW206152B (es) | 1991-03-20 | 1993-05-21 | Kuko Seiyaku Kk | |
ZA938116B (en) | 1992-10-30 | 1995-05-02 | Syntex Inc | Transdermal delivery of ketorolac |
DE19616539A1 (de) * | 1996-04-25 | 1997-11-06 | Luitpold Pharma Gmbh | Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel |
IT1291362B1 (it) | 1997-05-13 | 1999-01-07 | Vectorpharma Int | Composizioni farmaceutiche multicomponente bifasiche contenenti sostanze atte a modificare la partizione dei principi attivi |
US6083996A (en) | 1997-11-05 | 2000-07-04 | Nexmed Holdings, Inc. | Topical compositions for NSAI drug delivery |
EP1044684B1 (en) | 1999-04-13 | 2004-07-28 | Nitto Denko Corporation | Percutaneously absorbable preparation |
DE10025558A1 (de) | 2000-05-24 | 2001-11-29 | Merck Patent Gmbh | Topische Zusammensetzung, enthaltend mindestens ein Aryloxim, und Verfahren zu ihrer Herstellung |
CA2448627A1 (en) | 2001-05-31 | 2002-12-05 | Pharmacia Corporation | Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol |
JP2003095983A (ja) | 2001-09-21 | 2003-04-03 | Lion Corp | 皮膚外用剤組成物 |
AR041021A1 (es) | 2002-08-22 | 2005-04-27 | Novartis Consumer Health Sa | Composicion topica |
DE10255415A1 (de) * | 2002-11-28 | 2004-06-09 | Bayer Healthcare Ag | Dermale Applikation von Flupirtin |
US8907153B2 (en) | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
-
2007
- 2007-07-26 DE DE102007034976A patent/DE102007034976A1/de not_active Withdrawn
-
2008
- 2008-07-15 JP JP2010517293A patent/JP2010534624A/ja not_active Withdrawn
- 2008-07-15 EP EP08773993A patent/EP2182921A2/de not_active Withdrawn
- 2008-07-15 CA CA2694386A patent/CA2694386A1/en not_active Abandoned
- 2008-07-15 BR BRPI0814588-1A2A patent/BRPI0814588A2/pt not_active IP Right Cessation
- 2008-07-15 WO PCT/EP2008/005747 patent/WO2009012908A2/de active Application Filing
- 2008-07-15 CL CL2008002077A patent/CL2008002077A1/es unknown
- 2008-07-15 US US12/670,428 patent/US20100197791A1/en not_active Abandoned
- 2008-07-15 AU AU2008280501A patent/AU2008280501A1/en not_active Abandoned
- 2008-07-16 AR ARP080103051A patent/AR067561A1/es unknown
- 2008-07-16 PE PE2008001199A patent/PE20090797A1/es not_active Application Discontinuation
- 2008-07-16 UY UY31227A patent/UY31227A1/es not_active Application Discontinuation
- 2008-07-25 TW TW097128223A patent/TW200922622A/zh unknown
-
2010
- 2010-01-22 ZA ZA2010/00514A patent/ZA201000514B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2182921A2 (de) | 2010-05-12 |
CA2694386A1 (en) | 2009-01-29 |
CL2008002077A1 (es) | 2009-01-30 |
PE20090797A1 (es) | 2009-07-23 |
DE102007034976A1 (de) | 2009-01-29 |
WO2009012908A2 (de) | 2009-01-29 |
JP2010534624A (ja) | 2010-11-11 |
TW200922622A (en) | 2009-06-01 |
WO2009012908A3 (de) | 2009-06-11 |
BRPI0814588A2 (pt) | 2015-01-20 |
AU2008280501A1 (en) | 2009-01-29 |
ZA201000514B (en) | 2011-04-28 |
US20100197791A1 (en) | 2010-08-05 |
UY31227A1 (es) | 2009-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP099635A (es) | Formulaciones líquidas que forman una capa dérmica para la liberación de fármacos a la piel | |
CL2017000829A1 (es) | Formulación farmacéutica que comprende mezcla de anticuerpo anti-alfa4beta7, un agente tamponante, y citrato; uso de dicha formulación para tratar enfermedad inflamatoria del intestino. | |
ES2553742T3 (es) | Forma de dosificación farmacéutica que comprende 6'-fluor-(N-metil- o N,N-dimetil)-4-fenil-4',9'-dihidro-3'H-espiro[ciclohexano-1,1'-pirano[3,4,b]indol]-4-amina | |
CL2013003163A1 (es) | Composición transdermica de ibuprofeno, util en el tratamiento del dolor o la inflamacion. | |
AR084691A1 (es) | Formulacion de uso topico para un inhibidor de jak y metodo para tratar trastorno de la piel | |
GT200600445A (es) | Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo. | |
AR054249A1 (es) | Tratamiento de enfermedades del tejido conectivo de la piel | |
AR064268A1 (es) | Sistema terapeutico transdermico para administracion del principio activo buprenorfina | |
CL2011002858A1 (es) | Uso de una composicion farmaceutica transmucosa oral que comprende dexmedetomidina y una sal farmaceuticamente aceptable y un excipiente farmaceuticamente aceptable para preparar un medicamento util para tratar o prevenir el dolor. | |
AR080491A1 (es) | Formulaciones orales y sales lipofilicas de metilnaltrexona | |
AR054987A1 (es) | Composicion veterinaria trasmucosal | |
PE20141539A1 (es) | Una nueva composicion terapeutica que contiene apomorfina como principio activo | |
CL2013003630A1 (es) | Formulacion farmaceutica liquida que comprende nitisinona y un tampon de acido citrico que tien un ph en el rango de 2,5 a 3,5, de preferencia 3,0; y su uso para el tratamiento de tirosemia, enfermedad de parkinson, depresion, entre otros. | |
CO6280474A2 (es) | Composicion farmaceutica para el tratamiento de la eyaculacion precoz | |
UY30284A1 (es) | Compuestos de ariloxietilamina apropiados para tratar trastornos que responden a la modulacion del receptor de dopamina d3 | |
CL2010001577A1 (es) | Uso de nifurtimox para preparar un medicamento util en el tratamiento de enfermedades causadas por giardias. | |
AR065582A1 (es) | Mejoras en composiciones medicinales o relativas a las mismas | |
PE20110305A1 (es) | Combinacion farmaceutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y un nsaid | |
UY31790A (es) | Utilización de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia y que tienen un incremento del nivel de creatinina debido a la administración de dronedarona | |
UY31097A1 (es) | Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsionante | |
EA201390345A1 (ru) | Терапевтическое болеутоляющее средство | |
UY29989A1 (es) | Composiciones farmacéuticas de agentes hipnoticos de accion corta en forma de liberación modificada y los procedimientos para preparar dichas formulaciones | |
GT200800235A (es) | Formulacion de medicamento liquida | |
AR067561A1 (es) | Medicamento para la aplicacion transdermica en animales | |
AR086491A1 (es) | Composicion farmaceutica que comprende fexofenadina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |